Literature DB >> 10931060

Multicentre study of thyroid nodules in patients with Graves' disease.

J L Kraimps1, M H Bouin-Pineau, M Mathonnet, L De Calan, J Ronceray, J Visset, R Marechaud, J Barbier.   

Abstract

BACKGROUND: The association of Graves' disease with thyroid nodules and thyroid carcinoma is rarely reported. The incidence seems to be increasing according to recent literature. The aim of this multicentre study was to review patients who had surgery for Graves' disease associated with thyroid nodules, and to evaluate the risk of thyroid carcinoma.
METHODS: A retrospective study was made of 557 consecutive patients who underwent operation for Graves' disease between 1991 and 1997 in five endocrine surgery departments. Each patient underwent clinical, biochemical, ultrasonographic and scintigraphic evaluation. None of the patients had had previous radioactive iodine therapy or external irradiation. Surgery consisted of either a subtotal or total thyroidectomy.
RESULTS: Nodules were observed before operation in 140 patients (25.1 per cent). Thyroid carcinoma was diagnosed in 21 patients (15.0 per cent), always inside a nodule. The incidence of thyroid carcinoma associated with Graves' disease was 3.8 per cent (21 of 557 patients): 20 papillary and one follicular carcinoma. The carcinoma was multifocal in two patients. Tumour diameter ranged from 2 to 25 mm. A nodule was palpable in four patients.
CONCLUSION: This multicentre study of patients having thyroidectomy for Graves' disease showed that 3.8 per cent had a carcinoma; the rate of carcinoma in cold nodules was 15.0 per cent. Surgery should be advised in any patient with Graves' disease and a thyroid nodule; the operation should be total thyroidectomy.

Entities:  

Mesh:

Year:  2000        PMID: 10931060     DOI: 10.1046/j.1365-2168.2000.01504.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  19 in total

1.  Nodular thyroid disease. Abnormal thyroid function may be positive discriminator for malignancy.

Authors:  G L Sayer
Journal:  BMJ       Date:  2001-11-17

2.  Gray-scale three-dimensional sonography of thyroid nodules: feasibility of the method and preliminary studies.

Authors:  Rafal Z Slapa; Jadwiga Slowinska-Srzednicka; Kazimierz T Szopinski; Wiesław Jakubowski
Journal:  Eur Radiol       Date:  2005-09-10       Impact factor: 5.315

3.  Thyroid carcinoma in patients with Graves' disease: an institutional experience.

Authors:  Shuanzeng Wei; Zubair W Baloch; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2015-03       Impact factor: 3.943

4.  Safety and efficacy of surgical management of hyperthyroidism: 15-year experience from a tertiary care center in a developing country.

Authors:  P V Pradeep; Amit Agarwal; Mukta Baxi; Gaurav Agarwal; Sushil Kumar Gupta; S K Mishra
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

5.  Total thyroidectomy: a safe and effective treatment for Graves' disease.

Authors:  Jing Liu; Anna Bargren; Sarah Schaefer; Herbert Chen; Rebecca S Sippel
Journal:  J Surg Res       Date:  2011-01-26       Impact factor: 2.192

6.  Outcome of patients surgically treated for various forms of hyperthyroidism with differentiated thyroid cancer: experience at an endocrine center in Italy.

Authors:  Carlo Cappelli; Marco Braga; Elvira De Martino; Maurizio Castellano; Elena Gandossi; Barbara Agosti; Davide Cumetti; Ilenia Pirola; Chiara Mattanza; Laura Cherubini; Enrico Agabiti Rosei
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

7.  Cancer risk in patients with Graves' disease: a nationwide cohort study.

Authors:  Yen-Kung Chen; Cheng-Li Lin; Yen-Jung Chang; Fiona Tsui-Fen Cheng; Chiao-Ling Peng; Fung-Chang Sung; Ya-Hsin Cheng; Chia-Hung Kao
Journal:  Thyroid       Date:  2013-07       Impact factor: 6.568

8.  Simultaneous diffuse sclerosis variant of papillary thyroid carcinoma and diffuse toxic hyperplasia (Graves' disease).

Authors:  Gladell P Paner; Jennifer L Hunt; Marlyn C Ciesla; Steven DeJong; Virginia LiVolsi
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

9.  Predictive factors of thyroid cancer in patients with Graves' disease.

Authors:  Meng Ren; Mu Chao Wu; Chang Zhen Shang; Xiao Yi Wang; Jing Lu Zhang; Hua Cheng; Ming Tong Xu; Li Yan
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

10.  Alemtuzumab in multiple sclerosis: latest evidence and clinical prospects.

Authors:  Onajite Kousin-Ezewu; Alasdair Coles
Journal:  Ther Adv Chronic Dis       Date:  2013-05       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.